37 results
IDSA Suggested Empiric Antibiotic Regimens Based on Clinical Severity for Diabetic Foot Infections
Mild (usually treated with
IDSA Suggested Empiric ... Antibiotic Regimens ... Foot Infections ... #pharmacology # ... idsa #podiatry
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... annual monofilament foot ... pregabalin as treatment ... #Pharmacology # ... Management #Medications
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Aspergillosis #Treatment ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... #pharmacology #pharmacotherapy ... comparison #management #medications ... #treatment
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Osteomyelitis - IDSA ... Parenteral #IV #Antibiotics ... #pharmacology # ... idsa
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... Foot Infections ... and Duration of Antibiotic ... #Diabetic #Foot ... #pharmacology #
Metformin - First Line Treatment for Diabetes Type 2
• Start with initial dose of 500 mg
Metformin - First Line Treatment ... for Diabetes Type ... than stopping medication ... #Titration #Pharmacology ... #Diabetes #DM2
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... a Patient With Diabetic ... of nonsurgical treatment ... 48–72 h if on treatment ... renal failure) #Diabetic
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... Acquired #Pneumonia #Antibiotics ... #Treatment #Regimen ... Management #Guidelines #pharmacology